Navigation Links
Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission

hase 3 trial in women with brain metastases originating from breast cancer, and PDX (pralatrexate), a novel antifolate currently under evaluation in a pivotal Phase 2 trial in patients with relapsed or refractory peripheral T-cell lymphoma. The Company is also evaluating RH1, a targeted chemotherapeutic agent, in a Phase 1 trial in patients with advanced solid tumors. For additional information, please visit the Company's website at www.allos.com.

Safe Harbor Statement

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements relating to the potential safety and efficacy profile of PDX, the timeline for completion of patient enrollment in the PROPEL trial; and other statements that are other than statements of historical facts. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "intends," "plans," anticipates," "believes," "estimates," "predicts," "projects," "potential," "continue," and other similar terminology or the negative of these terms, but their absence does not mean that a particular statement is not forward-looking. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, among others: that the Company may experience delays in the initiation and/or completion of its clinical trials, whether caused by competition, adverse events, patient enrollment rates, regulatory issues or other factors; that clinical trials may not demonstrate that PDX is both safe and more effective than current standards of care; that the safety and/or efficacy results of clinical trials for PD
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
5. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
6. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
7. AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
10. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
11. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
Post Your Comments:
(Date:5/24/2013)... HILL, N.C. , May 24, 2013 /PRNewswire/ ... to the forefront of many organizations, priority list. ... and medical device sectors understand a strong ... current challenges in clinical development, market education ... effectively to create a vital bridge between an ...
(Date:5/24/2013)... FRANKLIN LAKES, N.J. , May 24, 2013  BD ... leading global medical technology company, announced today that it will ... Care Conference on Thursday, May 30, 2013, at 10:40 a.m. ... can be accessed from the BD corporate website at ... June 6, 2013.    About BD ...
(Date:5/24/2013)... May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses of ... abuse services organization, is hosting its tenth annual "Triumph ... on June 6, 2013.  More than 300 people are ... the adolescent residential treatment centers, family therapy, and prevention ... whose accomplishments have positive influences on the health and welfare ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... (Nasdaq: IDIX ) announced today that Idenix management ... Small Cap Healthcare Conference on Tuesday, September 14, 2010 at ... City and at the Stifel Nicolaus Healthcare Conference on Thursday, ... Seasons Hotel, Boston. The live and archived ...
... YORK, Sept. 7 Reportlinker.com announces that a ... catalogue: Cell Therapy - Technologies, ... SummaryThis report describes ... have already started to play an important role ...
Cached Medicine Technology:Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 2Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 3Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 4Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 5Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 6Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 7Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 8Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 9Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 10Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 11Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 12Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 13Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 14Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 15Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 16Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 17Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 18Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 19Reportlinker Adds Cell Therapy - Technologies, Markets and Companies 20
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 ... reported that many people do not wish to discuss or ... responsibility in life. FuneralFinancials.com released a Must-Do ... , 1. Funeral Financials recommends, “Creating a personal fact ... be used to organize financial information and personal data. ...
(Date:5/25/2013)... May 25, 2013 Pradaxa lawsuits ... life-threatening episodes of internal bleeding while using the blood thinner ... District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. ... Pradaxa side effect claims had been filed in ... from 705 claims reported by the Court on May 15th. ...
(Date:5/25/2013)... May 25, 2013 The latest ... from irritable bowel syndrome (IBS) to bloating, constipation, ... the most long-lasting, embarrassing, frustrating and difficult health ... for digestive health have provided a cure ... many factors contributing to digestive health issues, a ...
(Date:5/25/2013)... By working diligently for months on ... of the 2012 Lamborghini Aventador into their well-built fitments ... in the list of vehicles lined by SizeItUp for ... set to thrill automobile lovers in the year 2013. ... looks, the 2012 Lamborghini Aventador comes with extraordinarily spacious ...
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 ... organization dedicated to brain cancer research and advocacy, comments ... for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma ... glioblastoma cells. , According to a Science ... for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
... , CAMPBELL, ... radio show, Dr. Rafael Pelayo, Associate Professor at the Stanford Sleep ... Duet Sleep Sound Machine as part of a healthy sleep plan ... use of drugs. , "Background noise is a problem for people ...
... , CHICAGO, Dec. 2 A randomized, controlled ... called percutaneous disc decompression for painful herniated disc revealed that ... disc decompression kept patients pain free up to two years ... were presented today at the annual meeting of the Radiological ...
... ... and MTA: CTIC) announced today that Ruth Pettengell, M.D. of ... the PIX 301 EXTEND trial will present new data on ... (NHL) at the 51st Annual Meeting of the American Society ...
... presented today at the annual meeting of the Radiological ... evidence of the benefit of annual screening ultrasound for ... for breast cancer. In addition, the study confirmed that ... "We found that annual screening with ultrasound in ...
... , NEW ... market research report is available in its catalogue: , ... to 2015 , http://www.reportlinker.com/p0166596/Global-In-Vitro-Diagnostics-Market-Analysis-and-Forecasts-to-2015.html , Global ... , Summary , GlobalData,s "Global In Vitro ...
... ... announces that a new market research report is ... of Monoclonal Antibodies - Market Forecasts to 2015, ... , http://www.reportlinker.com/p0166816/The-Future-of-Monoclonal-Antibodies---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html , Summary ...
Cached Medicine News:Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 14Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 15Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 16Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 17Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 18Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 19Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 20Health News:Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 21Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8
... method for Dimension integrated chemistry systems ... in vitro diagnostic test intended to ... (TPSA) in human serum or plasma. ... in the detection of prostate cancer ...
... line of pregnancy tests including rapid membrane ... one-step stick and cassette formats. The Clearview ... HCG is a 25 mIU urine test ... HCG II provides 25mIU sensitivity for urine ...
... Laboratories offers a comprehensive line of pregnancy ... and urine in convenient one-step stick and ... testing options. Clearview Easy HCG is a ... stick format. Clearview HCG II provides ...
For the quantitative determination of Glycohemoglobin in blood....
Medicine Products: